Currently, there are 1.30B common shares owned by the public and among those 1.29B shares have been available to trade.
The company’s stock has a 5-day price change of -12.12% and -25.45% over the past three months. LRCX shares are trading -7.00% year to date (YTD), with the 12-month market performance up to 13.42% higher. It has a 12-month low price of $57.44 and touched a high of $113.00 over the same period. LRCX has an average intraday trading volume of 13.29 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.08%, -9.10%, and -18.79% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Lam Research Corp. (NASDAQ: LRCX) shares accounts for 85.95% of the company’s 1.30B shares outstanding.
It has a market capitalization of $94.41B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 25.11, while the earnings-per-share (ttm) stands at $2.90. The company has a PEG of 1.79 and a Quick Ratio of 2.00 with the debt-to-equity ratio at 0.62. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.86% over the week and 3.70% over the month.
Earnings per share for the fiscal year are expected to increase by 15.85%, and 23.75% over the next financial year. EPS should shrink at an annualized rate of 14.00% over the next five years, compared to 16.17% over the past 5-year period.
Looking at the support for the LRCX, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on August 01, 2024, with the firm’s price target at $1000-$1050. Jefferies coverage for the Lam Research Corp. (LRCX) stock in a research note released on May 13, 2024 offered a Buy rating with a price target of $1100. TD Cowen was of a view on April 25, 2024 that the stock is Buy, while B. Riley Securities gave the stock Buy rating on April 19, 2024, issuing a price target of $870- $1100. Needham on their part issued Buy rating on April 18, 2024.
